Related Experiment Video
Updated: Aug 5, 2025
Characterize Disease-related Mutants of RAF Family Kinases by Using a Set of Practical and Feasible Methods
Published on: July 17, 2019
Mutant K-Ras in Pancreatic Cancer: An Insight on the Role of Wild-Type N-Ras and K-Ras-Dependent Cell Cycle
Robert Ferguson1, Karen Aughton1, Anthony Evans1
1Liverpool Experimental Cancer Medicine Centre, University of Liverpool, Liverpool L3 5TR, UK.
Abstract:
The development of K-Ras independence may explain the failure of targeted therapy for pancreatic cancer (PC). In this paper, active N as well as K-Ras was shown in all human cell lines tested. In a cell line dependent on mutant K-Ras, it was shown that depleting K-Ras reduced total Ras activity, while cell lines described as independent had no significant decline in total Ras activity. The knockdown of N-Ras showed it had an important role in controlling the relative level of oxidative metabolism, but only K-Ras depletion caused a decrease in G2 cyclins. Proteasome inhibition reversed this, and other targets of APC/c were also decreased by K-Ras depletion. K-Ras depletion did not cause an increase in ubiquitinated G2 cyclins but instead caused exit from the G2 phase to slow relative to completion of the S-phase, suggesting that the mutant K-Ras may inhibit APC/c prior to anaphase and stabilise G2 cyclins independently of this. We propose that, during tumorigenesis, cancer cells expressing wild-type N-Ras protein are selected because the protein protects cancer cells from the deleterious effects of the cell cycle-independent induction of cyclins by mutant K-Ras. Mutation independence results when N-Ras activity becomes adequate to drive cell division, even in cells where K-Ras is inhibited.
Insights
K-Ras independence in pancreatic cancer (PC) may cause targeted therapy failure. N-Ras activity protects cancer cells from mutant K-Ras, enabling cell division even when K-Ras is inhibited.
Area of Science:
- Oncology
- Molecular Biology
- Cell Cycle Regulation
Background:
- Targeted therapy for pancreatic cancer (PC) often fails due to developing K-Ras independence.
- Both N-Ras and K-Ras are active in human cancer cell lines.
- K-Ras dependence is characterized by reduced Ras activity upon K-Ras depletion, unlike independent cell lines.
Purpose of the Study:
- To investigate the mechanisms underlying K-Ras independence in pancreatic cancer.
- To elucidate the roles of N-Ras and K-Ras in cell cycle regulation and oxidative metabolism.
- To understand how N-Ras may confer resistance to K-Ras targeted therapies.
Main Methods:
- Ras activity assays in human cell lines with varying K-Ras dependence.
- N-Ras and K-Ras knockdown experiments.
- Analysis of G2 cyclins, oxidative metabolism, and proteasome activity.
- Investigation of APC/c activity and cyclin ubiquitination.
Main Results:
- K-Ras depletion reduced total Ras activity in dependent cells but not in independent cells.
- N-Ras knockdown affected oxidative metabolism, while K-Ras depletion decreased G2 cyclins.
- K-Ras depletion slowed G2 phase exit and suggested mutant K-Ras inhibits APC/c, stabilizing G2 cyclins.
Conclusions:
- Wild-type N-Ras protein may protect cancer cells from detrimental effects of mutant K-Ras during tumorigenesis.
- N-Ras activity supports cell division, contributing to K-Ras mutation independence.
- Understanding these Ras isoform interactions is crucial for overcoming therapeutic resistance in pancreatic cancer.
Related Concept Videos
02:38The Ras Gene
Ras is a...
01:24Small GTPases - Ras and Rho
Three regulatory proteins control their activity:
03:03mTOR Signaling and Cancer Progression
The mTOR pathway or the...
02:23Abnormal Proliferation
01:23Negative Regulator Molecules
01:20The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...